Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_assertion type Assertion NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_head.
- NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_assertion description "[Interestingly, the compound also suppressed the growth of androgen-independent C4-2 and CWR22rv prostate cancer cells, which express a functional AR, but did not suppress the growth of the AR-negative prostate cancer cells PPC-1, DU145, and R3327-AT3.1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_provenance.
- NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_assertion evidence source_evidence_literature NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_provenance.
- NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_assertion SIO_000772 22798067 NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_provenance.
- NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_assertion wasDerivedFrom befree-20140225 NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_provenance.
- NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_assertion wasGeneratedBy ECO_0000203 NP453013.RA29nDfsk68tv9-Gg53qeGZqtk2gp3RKf39svJHixjnPA130_provenance.